Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium
- 1 May 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 35 (5) , 1104-1116
- https://doi.org/10.1053/jhep.2002.32528
Abstract
An angiogenic response originating from peritumoral sinusoids and portal tracts that leads to the formation of metastases with sinusoidal- and portal-type angiogenic patterns, respectively, occurs during the course of liver colonization by murine 51b colon carcinoma (51b-CC) cells. We found a 5-fold increase in endogenous endostatin levels from hepatic blood over baseline (25 ± 6 ng/mL) when micrometastatic foci had a detectable size and a 14-fold increase when macrometastases were developed. Despite this endogenous endostatin production, subcutaneous administration of recombinant human endostatin (rh-E; 50 mg/kg) decreased metastasis number by 60% when dosed from days 1 to 20 after 51b-CC cell injection, by 40% when given from days 10 to 20, and by 30% when administered as a single dose 30 minutes before 51b-CC cell injection compared with controls. In addition, administration of rh-E from days 10 to 20 decreased overall metastasis volume by 90% compared with controls. rh-E increased the number of necrotic sinusoidal-type metastases by 7-fold and decreased their intrametastatic CD31+-microvessel density by 80% without affecting portal-type metastases. Flow cytometry showed rh-E binding to mouse liver sinusoidal cells but not to CD45+ cells (leukocytes and Kupffer cells) or 51b-CC cells. Furthermore, rh-E induced sinusoidal endothelium cell apoptosis. In conclusion, despite the direct correlation between metastasis development and endogenous endostatin generation in the liver, administration of rh-E inhibited micrometastasis generation and macrometastasis growth very efficiently. The antiangiogenic mechanism was selective for sinusoidal-type metastases, in which the neovasculature originating from sinusoidal endothelium cells was targeted by rh-E.Keywords
Funding Information
- EntreMed Inc.
- University of the Basque Country, Leioa (13641/2001)
- Department of Education, University and Research from the Basque Country Government (EX-1999-125)
- Plan Nacional de I+D de la Comisión Interministerial de Ciencia y Tecnología to F.V.-V. (SAF99-0042)
- Department of Education, University and Research of the Basque Country Government
- University of the Basque Country
This publication has 18 references indexed in Scilit:
- Serum endostatin levels are elevated in patients with soft tissue sarcomaCancer, 2001
- Circulating levels of endostatin in cancer patients.Oncology Reports, 2001
- Angiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcimonaClinical Otolaryngology, 2000
- IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1Proceedings of the National Academy of Sciences, 2000
- Homeostatic Control of Angiogenesis: A Newly Identified Function of the Liver?Hepatology, 1999
- Zinc ligand-disrupted recombinant human Endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile.Angiogenesis, 1999
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasisHepatology, 1997
- Tumor angiogenesis in primary and metastatic colorectal cancersDiseases of the Colon & Rectum, 1996
- Isolation and enrichment of two sublobular compartment-specific endothelial cell subpopulations from liver sinusoidsHepatology, 1993